2142 Temozolimide and capecitabine in heavily pre-treated patients with KRASmut metastatic colorectal cancer. A phase II trial. (September 2015) - Qvortrup, C.; Keldsen, N.; Andersen, F.; Jensen, H.A.; Krogh, M.; Vestermark, L.W.; Christensen, G.; Bjerregaard, J.K.; Pfeiffer, P.